Cabotegravir/rilpivirine, sold under the brand name Cabenuva, is a co-packaged antiretroviral medication for the treatment of HIV/AIDS. It contains cabotegravir...

other drugs against HIV. In the European Union, rilpivirine is approved in combination with cabotegravir for maintenance treatment of adults who have undetectable...

for pre-exposure prophylaxis in the European Union. Cabotegravir in combination with rilpivirine is indicated for the treatment of human immunodeficiency...

Tivicay) cabotegravir (brand names Apretude [as a single agent indicated for PrEP]; and Vocabria/Cabenuva [when co-administered with rilpivirine for HIV...

[better source needed] Cabotegravir, developed by ViiV Healthcare, was approved in conjunction with rilpivirine by the FDA in January 2021 (cabotegravir/rilpivirine). Pirmitegravir...

Nevirapine J05AG02 Delavirdine J05AG03 Efavirenz J05AG04 Etravirine J05AG05 Rilpivirine J05AG06 Doravirine J05AH01 Zanamivir J05AH02 Oseltamivir J05AH03 Peramivir...

Johnson &. "Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV". www...

combination of the integrase inhibitor, cabotegravir, and the non-nucleoside reverse transcriptase inhibitor, rilpivirine, in a long-acting injectable form...

Atazanavir/cobicistat Bictegravir/emtricitabine/tenofovir alafenamide° Cabotegravir/rilpivirine Darunavir/cobicistat Darunavir/cobicistat/emtricitabine/tenofovir...

084-01 (The LIFT Study) is a clinical trial examining whether injectable cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) is safe and acceptable for...